Radioimmunotherapy of human pancreatic cancer xenografts in NOD-scid mice with [64Cu]Cu-NOTA-panitumumab F(ab′)2 alone or combined with radiosensitizing gemcitabine and the PARP inhibitor, rucaparib-Reference-Cited by-同舟云学术

Radioimmunotherapy of human pancreatic cancer xenografts in NOD-scid mice with [64Cu]Cu-NOTA-panitumumab F(ab′)2 alone or combined with radiosensitizing gemcitabine and the PARP inhibitor, rucaparib

Published:2020-05 Issue: Volume:84-85 Page:46-54
ISSN:0969-8051
Container-title:Nuclear Medicine and Biology
language:en
Short-container-title:Nuclear Medicine and Biology

Author:

Boyle Amanda J.,Cao Ping-Jiang,Cai Zhongli,Chan Conrad,Hedley David W.,Reilly Raymond M.

Funder

Canadian Cancer Society

Cancer Research Society

Publisher

Elsevier BV

Subject

Cancer Research,Radiology Nuclear Medicine and imaging,Molecular Medicine

Reference35 articles.

1. Pancreatic cancer;Kamisawa;Lancet,2016

2. FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer;Conroy;N Engl J Med,2011

3. Prognostic factors in resected pancreatic adenocarcinoma: analysis of actual 5-year survivors;Cleary;J Am Coll Surg,2004

4. Imaging preoperatively for pancreatic adenocarcinoma;Pietryga;J Gastrointest Oncol,2015

5. Targeting EGFR in pancreatic cancer treatment;Troiani;Curr Drug Targets,2012

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Relative Biological Effectiveness (RBE) of [64Cu]Cu and [177Lu]Lu-NOTA-panitumumab F (ab')2 radioimmunotherapeutic agents vs. γ-radiation for decreasing the clonogenic survival in vitro of human pancreatic ductal adenocarcinoma (PDAC) cells;Nuclear Medicine and Biology;2023-07

2. Preclinical Evaluation of a 64Cu-Based Theranostic Approach in a Murine Model of Multiple Myeloma;Pharmaceutics;2023-06-25

3. Multifunctional high-Z nanoradiosensitizers for multimodal synergistic cancer therapy;Journal of Materials Chemistry B;2022

4. Perspectives on metals-based radioimmunotherapy (RIT): moving forward;Theranostics;2021